USA VC Funds

LDV Capital, founded in 2012 and based in New York, is a venture capital firm specializing in early-stage investments in visual technology and artificial intelligence. The firm focuses on backing deep technical teams across North America and Europe that leverage computer vision, machine learning, and AI to analyze visual data. LDV Capital's investments span various industries, including healthcare, agriculture, manufacturing, and content creation. The firm has a robust network of computer vision experts, serial entrepreneurs, and technical advisors, which it uses to support its portfolio companies. Notable investments include Clarifai, Uizard, Synthesia, and Ezra, reflecting LDV's commitment to innovative visual tech solutions. LDV Capital's founder and General Partner, Evan Nisselson, brings extensive experience as a serial entrepreneur and digital media expert. LDV Capital hosts an annual summit dedicated to visual technologies and maintains a strong community through monthly dinners and networking events, fostering collaboration and innovation within its portfolio and the broader tech ecosystem. The firm recently closed its fourth fund at $31 million, continuing its mission to support groundbreaking visual technology startups.

Lead Edge Capital is a growth equity firm managing over $5 billion in assets, with a focus on software, internet, and tech-enabled businesses. The firm invests in both private and public companies, typically deploying between $25 million and $300 million. Notable portfolio companies include Alibaba, Toast, Grafana, and Wise, showcasing a strong track record across diverse sectors. The firm’s strategy revolves around leveraging its extensive network of 700+ executives and industry leaders to drive growth through strategic partnerships and customer acquisition. Lead Edge is highly flexible, offering both minority and buyout investments to companies with $10 million+ in revenue and 25%+ year-on-year growth. Geographically, Lead Edge operates from New York and Santa Barbara but invests globally. They typically engage in late-stage funding rounds, often as co-investors, and aim to bring more than just capital to the table. Founders benefit from Lead Edge’s vast network, which is a key part of their value proposition. The team is led by professionals like Evan Skorpen (Partner, Public Markets), with deep expertise in tech and finance. Startups looking to engage should focus on demonstrating scalable growth and recurring revenue models to catch their attention.

Leading Edge Ventures is a micro venture capital firm founded in 2014 and based in Newark, Delaware, investing in seed and early-stage technology companies in the Mid-Atlantic corridor. The firm raised approximately $10 million in its first fund to back entrepreneurs in Delaware, Eastern Pennsylvania, Maryland, and New Jersey. The team of seven includes six partners: Doug Petillo, Rick Birkmeyer (CEO of CD Diagnostics), Vance Kershner (Founder and CEO of LabWare Inc.), and Mike Bowman (Associate Director at the University of Delaware's Office of Economic Innovation and Partnerships), among others. The partnership brings strong ties to the University of Delaware and the regional business and academic community. Leading Edge invests $50,000 to $250,000 initially with the ability to follow on up to $750,000 per company over time, focusing on IT (software, cloud-based applications, and tech-enabled services) and MedTech (devices, equipment, and diagnostics) sectors. The fund has made 20 investments, achieving 4 acquisitions including College Ave, Pliant, and OThot. Other named portfolio companies include scaleMatters (most recent investment, June 2021) and Bonsai. The fund appears fully deployed and in harvest mode with no investments tracked since mid-2021. Leading Edge's partners bring operational expertise as founders and CEOs alongside academic and government innovation roles, giving the firm a credible position among early-stage entrepreneurs in a region that has traditionally been underserved by institutional venture capital. The firm emphasizes backing exceptionally talented entrepreneurs with innovative technologies in high-demand markets, with the goal of catalyzing a broader Mid-Atlantic startup ecosystem.

Leadout Capital, founded in 2018 by Alison Rosenthal, is an early-stage venture capital firm based in Portola Valley, California. The firm focuses on investing in companies led by diverse founders, with over 85% of their portfolio companies led by women or underrepresented minorities. Notable investments include AtoB, Syky, and LifeRaft, which highlight their commitment to sectors such as business productivity software, financial services, and insurance technology. Leadout Capital's investment strategy is centered on founder-market fit, backing resilient entrepreneurs who possess deep expertise in their respective fields. They prioritize companies with strong network effects, unique data sets, and long-term defensibility. The average check size ranges from $100K to $3M, primarily in seed and early-stage rounds. They are known for leading rounds and offering extensive support, including fundraising assistance, customer introductions, and strategic advisory. The firm is proactive in sourcing deals through its extensive network and places significant emphasis on diversity and inclusion. Leadout Capital's team, including General Partner Steve Brownlie and Venture Partner Yun-Fang Juan, brings a wealth of experience and strategic insight to their portfolio companies. Headquartered in Portola Valley, Leadout Capital is dedicated to fostering innovation and supporting the next generation of diverse entrepreneurs in technology sectors like AI, blockchain, and fintech.

Leap Venture Studio is the world's first and largest pet care startup accelerator, founded in 2018 as a joint initiative between Mars Petcare, the world's largest pet care company, Michelson Found Animals, an animal welfare organization, and TAW Ventures, founded by Jane Lauder. Based in Los Angeles, the program selects 6 to 8 companies per cohort and runs a 12-week accelerator offering $200,000 in funding per startup. Rachel Sheppard (Director of Ventures, Mars Petcare) and Phillip Kim (Executive Director, Michelson Philanthropies) co-lead the program. As of 2025, Leap Venture Studio has run 9 cohorts and invested in 57 companies across 17 markets globally. Portfolio companies have collectively raised over $200 million in follow-on capital. The studio invests at pre-seed and seed stages and leads rounds. Cohort 9, which kicked off in Nashville in 2025, featured companies including BistroCat, Buddy Bites, Happy Howl, James and Ella, and Petcademy. Cohort 10 is scheduled for August through November 2026, with a focus on pet longevity, wellness, and senior pet care. The portfolio spans pet food and nutrition, pet health diagnostics, pet technology, and animal welfare. Two successful exits have been achieved: PetHospice and Lacuna Diagnostics. Leap selects companies based on traction, product-market fit, in-market learnings, team composition, and demonstrated social impact. The program includes the Leap Venture Academy, providing educational and support programming beyond the core accelerator curriculum. Mars Petcare's global distribution network, brand relationships, and retail reach give portfolio companies an unparalleled commercial development partner at the earliest stage of company formation.

Leaps by Bayer, founded in 2015, is Bayer AG's strategic impact investment unit focusing on transformative biotechnologies in health and agriculture. Since its inception, Leaps by Bayer has invested over $1.9 billion in more than 60 ventures, targeting significant challenges through ten key "leaps" designed to address pressing global issues. Key investments include Recursion Pharmaceuticals, which focuses on drug discovery using AI, and BlueRock Therapeutics, a company specializing in cell therapy. These investments align with their strategic goals such as curing genetic diseases, developing sustainable organ and tissue replacements, and reducing the environmental impact of agriculture. Leaps by Bayer's portfolio companies operate autonomously, but benefit from Bayer’s active incubation model, which provides resources and strategic guidance. This approach helps them focus on long-term, high-impact results rather than short-term gains. Leaps by Bayer also collaborates globally with partners in industry, academia, and civil society to drive these innovations forward.

Learn Capital is a venture capital firm focused on backing early-stage companies that transform education and empower individuals to thrive. Founded by Rob Hutter, the firm specializes in tech-enabled startups that are revolutionizing how people learn and grow across various sectors. Learn Capital has made high-profile investments in education technology companies such as Coursera, Udemy, and Photomath, which provide accessible, world-class learning opportunities globally. The firm operates with a mission to accelerate human flourishing, supporting ventures that tackle some of the world's biggest human-centered challenges. Their investment thesis is centered on companies that offer tools for personal development and skill-building, helping individuals unlock their full potential. Learn’s portfolio spans education, work productivity, and health, highlighting their commitment to solving real-world problems with innovative, scalable solutions. Based in San Mateo, California, Learn Capital currently manages over $1 billion in assets and has invested in 176 companies. They focus on seed and early-stage investments, providing not just capital, but also strategic guidance and operational support to help companies scale rapidly​.

LearnStart is an early-stage venture capital fund focusing on educational technology (edtech). Managed by Don Burton and Michael Staton, the fund is dedicated to fostering innovation in global education through strategic seed investments. Their portfolio includes companies like ClassDojo, Andela, and Degreed, highlighting their emphasis on transformative learning technologies. The fund operates primarily out of New York and San Francisco, investing in startups that range from e-learning platforms to AI-driven educational tools. LearnStart typically leads investment rounds, writing checks in the range of $1 million to $5 million. They have an impressive track record, with multiple portfolio companies achieving significant market impact and growth. Startups looking to engage with LearnStart should demonstrate a strong potential for innovation in the education sector. The team offers not only capital but also valuable strategic advice and access to a broad network of industry experts and co-investors.

Leawood Venture Capital, established in 2016, is an early-stage investment firm based in Leawood, Kansas. The firm is dedicated to backing disruptive technology companies, with a particular focus on sectors such as artificial intelligence, data analytics, cybersecurity, fintech, and edge computing. Leawood's approach is highly strategic, leveraging its team’s deep experience and national network to help portfolio companies scale and succeed. Typically investing between $2 to $4 million, Leawood often leads or co-leads investment rounds in high-potential companies. The firm has made notable investments in businesses like Sorcero, which develops AI solutions for the life sciences industry, and InsightRX, a leader in precision medicine using machine learning and clinical algorithms to optimize patient treatment. Other portfolio highlights include companies in areas like telecommunications, predictive analytics, and AI-driven customer experience platforms. Leawood’s founding partners, Karl Gemperli and Brendan Fallis, bring decades of operational and entrepreneurial expertise. Gemperli, with a background in industrial IoT and wireless technologies, and Fallis, a former executive at Verizon Wireless, offer invaluable experience in scaling technology ventures. Alongside managing director Todd Daniels and a seasoned investment committee, the team provides hands-on support to startups, from business development to financial operations. With a focus on creating long-term value, Leawood Venture Capital continues to be a key player in supporting early-stage tech companies across the U.S., using their industry knowledge and vast networks to drive innovation and growth.

Left Lane Capital is a prominent venture capital firm headquartered in Brooklyn, New York, with an additional office in London. Founded in 2019, the firm specializes in investing in high-growth internet and consumer technology companies. Their mission is to support companies that are driving the digitization of the real economy by providing them with actionable insights and operational support to achieve hyper-scale growth. The firm's investment portfolio includes notable companies such as GoStudent, Jackpocket, and Bilt Rewards. GoStudent is a Vienna-based digital marketplace for online tutoring, Jackpocket is a mobile lottery platform, and Bilt Rewards is a consumer finance and rewards company focused on property renters. Other significant investments include Talkiatry, a behavioral healthcare company, and Blinkist, a service that provides key insights from non-fiction books in audio and text formats. Left Lane Capital typically invests between $5 million and $75 million, often leading or co-leading rounds. They focus on sectors such as fintech, healthtech, e-commerce enablement, and SaaS, supporting both B2B and B2C business models. The firm prides itself on a data-driven approach and a deep understanding of their portfolio companies' markets and customers. The team is led by founder and CEO Harley Miller, along with managing partners Avneet Pujji, Daniel Ahrens, and Jason Fiedler. They bring extensive experience and a commitment to working closely with founders to navigate the challenges of scaling businesses.

Legatum Ventures is the venture capital arm of the Legatum Group, a multibillion-dollar private investment firm founded in December 2006 by New Zealand-born billionaire Christopher Chandler. Headquartered in Legatum Plaza at the Dubai International Financial Centre — a building the group purchased in 2012 — the firm invests proprietary capital only, with no external limited partners. In 2015 Legatum transitioned to a partnership structure led by Christopher Chandler, Mark Stoleson, Philip Vassiliou, and Alan McCormick. The broader Legatum Group operates through multiple entities: Legatum Capital (public markets and private equity), Legatum Ventures (startup and growth investments), Legatum Foundation (philanthropy, including the annual Prosperity Index covering 107 countries), and the Legatum Institute (a policy think tank in London). Legatum Ventures invests at Series A through late-stage with check sizes in the $3 million to over $10 million range, without leading rounds. The portfolio spans approximately 7 tracked investments in fintech, media, AI, legal services, and consumer goods. Notable portfolio companies include Tomorrow.io, an AI weather satellite constellation company valued at over $1 billion, and GB News, the British broadcaster in which Legatum co-invested alongside Sir Paul Marshall, receiving over 34 million pounds in 2025. The most recent investment was Right Legal Group in January 2024, and the most recent exit was Dali Foods Group in July 2024. Legatum's investment strategy reflects a global, long-horizon approach — targeting listed companies, markets in economic transition such as Japan and China, and distressed situations — with an overarching mission to increase prosperity worldwide. The firm's combination of proprietary capital, long investment horizon, and cross-border operational presence gives it flexibility that external-LP funds cannot replicate.

LEGO Ventures is the corporate venture capital arm of the LEGO Brand, founded in 2018 and headquartered in Billund, Denmark. The firm invests in the future of creativity, learning, and play, aligned with the LEGO Idea of learning-through-play and the development of systematic creativity. Investment focus spans four key segments: Education Technology, 21st Century Skill Development, New Play Spaces, and Creative Making, with additional interest in gaming, climate technology, and AI. The fund is led by Parin Shah as Head of Ventures and is deeply integrated with KIRKBI, the Kirk Kristiansen family office that owns 75 percent of the LEGO Group. LEGO Ventures leads rounds and invests from seed through late stage, with average deal round sizes of approximately $14 million and maximum check sizes of $5 million. The firm has made 13 direct investments, with 3 lead positions. Typical deals attract 7 co-investors; common co-investors include Novator, Makers Fund, LVP, Northzone, and New Life Ventures. Named portfolio companies include Klang Games (ambitious multiplayer gaming), Thrively (skills-based learning platform), Monti Kids (Montessori-based learning for young children), Evolve Additive Solutions (3D printing and additive manufacturing), and Peppy Pals (social-emotional learning through play, exited June 2022). The firm also operates a Venture Incubation Studio that pairs LEGO employees with external entrepreneurs. LEGO Ventures brings a uniquely credible strategic position to its portfolio companies: access to one of the world's most recognized consumer brands, a global retail footprint, and deep expertise in child development, play science, and creative education. For startups building at the intersection of technology, learning, and play, LEGO's brand equity and distribution relationships offer commercial advantages that financial capital alone cannot provide.

Lemhi Ventures is a healthcare-focused venture capital firm founded in 2006 and based in Wayzata, Minnesota. The firm was established with a deliberate thesis: to use venture capital as the engine of change in healthcare services, with a focus on disruptive innovation, technology, and data as the keys to better health outcomes, lower costs, and greater consumer control. Now on Fund III, the team of five includes four partners: Tony Miller (Managing Partner), Matt Scholl (General Partner), John Park (Partner and co-founder of Definity Health), and Jodi Hubler. Lemhi leads rounds and invests primarily at Series A and B stages in US-based healthcare services companies. The firm has made 17 tracked investments across Funds I, II, and III. The exit record is particularly strong: 11 acquisitions out of 17 investments, including PlanSource, PokitDok, ABILITY, and Digital Reasoning (acquired by Smarsh in November 2020 for its cognitive computing capabilities). The latest investment was Harbor Health at Series A in January 2024, a health system that bears 100 percent financial risk with its members and payers while delivering better outcomes at lower cost. Other current portfolio companies include Aegle Health Partners, which operates a proprietary on-demand financing system for high-cost medical claims. Lemhi's partners are former founders, CEOs, and growth executives who have built companies reaching $100 million-plus in revenues and $1 billion-plus in valuations. This operational background shapes an investment approach grounded in the real challenges of scaling healthcare businesses: regulatory complexity, payer dynamics, clinical workflow adoption, and the long sales cycles inherent to health system customers. The firm averages approximately one new investment per year, reflecting a high-conviction, selective deployment strategy.

Lemnos VC, founded in 2011 and headquartered in San Francisco, is a venture capital firm specializing in early-stage investments in hardware and robotics startups. They typically invest at the pre-seed, seed, and Series A stages, focusing on companies that are pushing the boundaries of technology in fields such as aerospace, agriculture, logistics, and manufacturing. Some of their notable investments include Spire, Compology, Airware, and FORT Robotics. Lemnos VC provides extensive support to its portfolio companies, not just in terms of capital but also through strategic guidance and industry expertise. This holistic approach helps startups navigate the complex journey from conception to market success. The firm is led by experienced professionals like Managing Director Eric Klein, who brings significant expertise from his previous roles in advanced engineering and venture capital.

The LEO Foundation is one of Denmark's largest commercial foundations, primarily focused on supporting research in dermatology. Established in 1984, it is the controlling shareholder of LEO Pharma, a leading company in medical dermatology with a strong R&D pipeline. The foundation’s main objective is to ensure the long-term development and success of LEO Pharma while also providing philanthropic grants to advance skin disease research globally. The foundation holds financial assets worth approximately EUR 2.2 billion. Their investment strategy emphasizes generating attractive returns to support LEO Pharma’s strategic growth and funding their philanthropic activities. The portfolio is diversified across asset classes, including listed shares, bonds, and alternative investments like private equity and real estate. Investments are managed by a small team within their subsidiary, LEO Holding A/S, and through external professional asset managers. In 2022, the foundation awarded DKK 125 million across 36 grants to support diverse dermatological research projects. They also faced challenges from a tough macroeconomic environment, resulting in a negative return on investments. However, the foundation remains committed to its long-term goals, including enhancing its grant-giving capacity and supporting LEO Pharma’s profitability and growth strategies.

Lerer Hippeau is a prominent seed-stage venture capital firm based in New York City. Founded in 2010, it has built a strong reputation for backing early-stage startups with transformative potential. The firm has invested in over 400 companies, including notable successes like Warby Parker, Allbirds, BuzzFeed, Oscar Health, and ClassDojo. Their portfolio spans various sectors, with significant investments in consumer products, enterprise software, healthcare, fintech, and media. Lerer Hippeau's investment strategy focuses on partnering with innovative founders and providing extensive support to help them grow. They typically invest in seed and early-stage rounds but also participate in follow-on investments to support the continued growth of their portfolio companies. The firm is known for its hands-on approach and deep network, which they leverage to help startups scale. Key figures at Lerer Hippeau include managing partners like Ben Lerer, Eric Hippeau, and Graham Brown, who bring a wealth of experience and industry insight. The firm is recognized for fostering a collaborative and founder-friendly culture, making it a preferred choice for many early-stage entrepreneurs looking for more than just capital. Lerer Hippeau’s notable unicorns include SeatGeek, ClassDojo, and Genies, among others. The firm has also seen several successful IPOs, including companies like Allbirds and Warby Parker, further establishing its reputation as a leading early-stage investor. For startups aiming to connect with Lerer Hippeau, it's beneficial to showcase innovative solutions with strong market potential, aligning with the firm’s focus on supporting transformative and high-growth ventures​.

Levitate Capital is a venture capital firm dedicated to investing in the future of air mobility, drones, and space technology. Based in the San Francisco Bay Area, Levitate Capital focuses on early-stage ventures that are pioneering the next generation of transportation and logistics through advanced air and space technologies. The firm’s investment strategy covers a wide range of innovative companies, from those developing electric and autonomous flight systems to those building the infrastructure and business models necessary to support these emerging industries. Levitate Capital is driven by the belief that we are on the brink of a revolution in how airspace is utilized, not just for transportation but also for security, data capture, and global development. Their portfolio includes groundbreaking companies like Joby Aviation, the first publicly listed eVTOL (electric vertical take-off and landing) company, and Volocopter, a leading electric air taxi service provider. Additionally, they invest in enabling technologies such as Skydio, a leader in autonomous drone technology, and Spire Global, which provides satellite data and analytics. The firm’s approach is not only to back these high-tech ventures financially but also to support them in realizing their full potential within the rapidly evolving air mobility landscape. Levitate Capital’s focus on sustainable and innovative solutions positions them at the forefront of the transformation in how humanity interacts with the skies.

Lewis & Clark Ventures is an early-stage venture capital firm based in St. Louis, Missouri, specializing in B2B software investments. Founded by former founders and operators, the firm leverages its team's extensive entrepreneurial experience to partner with dynamic founders aiming to build successful companies. They focus on late seed to Series A investments, typically ranging from $2 million to $3 million per initial investment. The firm's portfolio includes innovative companies like Beam Benefits, Benson Hill, and GreenLight Biosciences. Lewis & Clark Ventures is known for its hands-on approach, often taking board seats and providing strategic, technical, and commercial support to help their portfolio companies scale effectively. Their investment strategy targets high-growth opportunities in overlooked geographies, emphasizing the importance of founder vision, team strength, and market potential. The firm values transparency, smart growth, and long-term partnerships, aiming to support founders not just with capital but also with mentorship and access to their extensive networks.

Lexi Ventures is a Menlo Park-based venture capital firm founded in 2023 by Jonah Probell, focused exclusively on seed-stage genetic engineering startups. Branded as Genetic Engineering Capital, the firm invests in US-based companies building around DNA, RNA, cells, and omics technologies. Probell brings 25 years of startup experience across seven companies in founder, executive, and engineering roles, having achieved two IPOs, 16 granted patents, and authored two books. The firm's thesis is that the genetic engineering revolution will be among the most value-creating venture categories of the next decade, as biology has transitioned from science to engineering. Lexi invests $50,000 to $500,000 with a sweet spot of $250,000, deploying approximately 10 investments annually and ranking among the top 20 VC funds active in the gene tech niche. The portfolio of 11-plus companies includes Kopra Bio (T-cell immunotherapy for solid tumors, most recent investment October 2025), ParcelBio (programmable mRNA delivery), KiraGen Bio (high-fidelity CRISPR tools, raised $2.5 million, Harvard Innovation Lab), QUiCKR Bio (gene editing quality control), Melio (rapid newborn pathogen diagnostics), AlkaLi Labs (biomining with microbes for critical minerals), Glyphic Bio (single-molecule protein sequencing), Syntensor (AI simulation for clinical trials), TippingPoint (precision genetic medicines for rare pediatric diseases), Taxa (bio-engineered probiotic skincare), and Crank Bio (RNA-based antisense therapeutics for rare diseases). Co-investors include IndieBio/SOSV and Activate Global. Lexi Ventures participates in the BIO Investor Forum and operates as a specialist conviction fund, aiming to be the first check for founders building at the frontier of genetic engineering. The firm's narrow focus gives it genuine domain depth — Probell evaluates deals not as a financial generalist but as someone who has built and scaled scientific companies from the lab bench outward.

Leyden Ventures is a Dubai-based venture capital firm founded in 2016 and co-founded by Mohamed Hamdy as General Partner. The firm takes its name from the Leyden jar, the first device for storing electric charge, invented in 1745 in Leiden, Netherlands — an analogy for the firm's goal of concentrating and channeling energy into transformative technology companies. Leyden invests across stages in developed markets with a focus on US-based B2B software companies led by domain entrepreneurs, also backing startups across Europe and MENA from pre-seed through Series A. The firm has made 35 investments, building a portfolio with two IPOs — Instacart and Coinbase — and multiple acquisitions including TruOptik (acquired by TransUnion), Mint Songs (acquired by Napster), and Picks and Shovels (acquired by Kraken). Active portfolio companies include Stripe, Superhuman, NexHealth, Pipe, Placer, Nothing (consumer electronics), Oxio (telecom), Soter Insure, Kinema, Vivoo, and LatelyAI. The most recent investment was Optimal AI in February 2025, an automation and workflow software company. The firm also operates an AngelList syndicate for co-investment opportunities. Alongside its investment activity, Leyden operates a management advisory practice under the Team Leyden banner, helping government entities, family offices, and traditional enterprises create startup communities, launch venture initiatives, and digitally transform. Advisory engagements have included Techstars Dubai, Area 2071, Dubai Holding, and Abu Dhabi Media. This dual operating model — active investor and strategic advisor — gives Leyden a distinctive cross-border position in the MENA venture ecosystem, bridging US technology deal flow with regional capital and commercial networks.

Liberty City Ventures, founded in 2012 and headquartered in New York City, is a venture capital firm focusing on early-stage investments in startups that innovate at the intersection of technology, media, and commerce. The firm primarily targets sectors such as fintech, big data and analytics, cybersecurity, e-commerce, IoT, and SaaS. Their diverse portfolio includes notable companies like Paxos, a blockchain infrastructure platform; Lukka, which provides institutional-grade financial software for crypto assets; and Animoca Brands, a leader in digital entertainment and blockchain gaming. Liberty City Ventures has made 81 investments and has seen 15 successful exits, including companies like TripleLift, a programmatic ad technology firm, and Curv, a digital asset security platform acquired by PayPal. Liberty City Ventures is led by experienced founders and partners such as Murtaza Akbar, Charles Cascarilla, and Emil Woods. The firm emphasizes supporting its portfolio companies with not just capital, but also strategic guidance and a robust network to help drive growth and innovation.

Liberty Global Ventures, now branded as Liberty Growth, is the corporate venture capital arm of Liberty Global, one of the world's largest international cable and telecom companies operating across 13 countries. Founded in 2005 and headquartered in Denver, Colorado, the fund is managed by a dedicated team in Denver, Palo Alto, London, and Amsterdam. With approximately $3 billion in assets under management and a portfolio valued at roughly $3.4 billion across 70-plus companies, Liberty Growth is one of the largest and most active CVCs in the technology, media, and telecommunications sector. The fund is stage-agnostic, investing from early-stage pre-revenue companies through late-stage growth with deal sizes typically ranging from $2 million to $20 million, with follow-on capability. Liberty Global Ventures has made 91 total investments and leads rounds. The portfolio includes active unicorns Aviatrix, Pax8, and Sorare, as well as strategic stakes in ITV (broadcasting), Univision (media), Plume (smart home), Lionsgate (entertainment), and Formula E (motorsport). The most recent named investment was ElevenLabs in 2025, preceded by Enfabrica's Series C in November 2024 (semiconductor networking). The most recent portfolio exit was Lacework in June 2024. In 2021 the fund announced a strategic partnership with Avesta Capital. Liberty Growth leverages Liberty Global's operational resources, international market presence across 13 countries, and infrastructure expertise to help portfolio companies accelerate growth. The fund's rebranding from Liberty Global Ventures to Liberty Growth reflects the parent company's broader operational restructuring into Liberty Telecom, Liberty Growth, and Liberty Services divisions. For founders building in technology, media, or telecommunications infrastructure, Liberty Growth offers both financial capital and direct commercial relevance across European and US markets.

Liberty Hall Capital Partners is a private equity firm based in Charleston, South Carolina, that focuses exclusively on investments in the global aerospace and defense industry. Since its inception in 2005, Liberty Hall has invested over $2.5 billion in equity capital across 28 acquisitions, including both platform and add-on acquisitions. Notable current investments include Accurus Aerospace Corporation, a supplier of engineered structural parts and assemblies; Comply365, a provider of compliance and data intelligence technologies; and Dunlop Aircraft Tyres, a designer and supplier of aircraft tires​​. The firm’s investments span across significant commercial, business jet, military aircraft platforms, and select space platforms. Liberty Hall's investment strategy is to leverage its extensive industry expertise and network to support portfolio companies in achieving significant growth and operational improvements. The firm is recognized for its hands-on approach and deep involvement in the strategic development of its portfolio companies.

Liberty Mutual Strategic Ventures (LMSV) is the corporate venture capital arm of Liberty Mutual Insurance, founded in 2016 and based in Boston, Massachusetts. The fund invests in early-stage insurtech, fintech, and enterprise software companies shaping the future of insurance, with a focus on areas strategically relevant to Liberty Mutual's global, diversified property and casualty insurance operations. Managing Director Russ MacTough leads the team alongside Directors Josh Cohen and Dave DeSisto. The fund launched a $150 million Fund I in 2015 and followed with a $200 million Fund II in July 2024, bringing total committed capital to $350 million. LMSV primarily invests from seed through Series B with initial check sizes of $750,000 to $5 million, and leads rounds while also co-investing alongside other venture funds. The portfolio has grown to 43 investments including Trunk Tools (Series B, July 2025, construction AI), Pano AI (June 2025, wildfire detection), Roots Automation (Series B, October 2024, $22.2 million raised for insurance process automation), Blueprint Title, Crux, Driver, Edge Case Research, Homee, and Hyro. Investment focus areas span AI, data and automation, cybersecurity, energy transition, and mobility. The fund has achieved 4 exits, with Azibo the most recent in May 2025. LMSV operates within Liberty Mutual's broader Enterprise Strategy and Innovation function, giving portfolio companies direct access to one of the largest US insurance groups as a potential commercial partner, pilot customer, and distribution channel. The fund's focus on technology transforming insurance — from underwriting automation and claims AI to climate risk intelligence and mobility insurance — reflects the view that the insurance industry is in the early innings of a technology-driven reinvention.

LifeForce Capital, founded in 2015 and based in San Francisco, specializes in investing in healthcare companies that are advancing care delivery through innovative technologies and new care models. They focus on digital health startups that enable new therapeutic development and efficient care delivery. Some of their notable investments include Notable Labs, which leverages AI for precision oncology, Clover Health, a technology-driven health insurance company, and One Medical, a membership-based primary care platform. LifeForce Capital targets early to late-stage ventures, with a typical investment ranging from seed to Series B. They emphasize a software-first approach, aiming to drive a paradigm shift in healthcare. Their strategy involves supporting companies that offer scalable solutions with significant potential for improving patient outcomes and healthcare efficiency. The firm has a solid track record with successful exits such as Cricket Health and TARA Biosystems. The investment team, led by founder John Noonan, includes experts like Dr. Dora Hughes and Nathaniel Bays, who bring extensive experience in healthcare investment and operations. For entrepreneurs, LifeForce Capital looks for groundbreaking innovations that align with their mission to reshape healthcare. Startups are advised to present clear, impactful solutions that demonstrate potential for significant advancements in care delivery and therapeutic development​.

Lightbank, founded in 2010 by Brad Keywell and Eric Lefkofsky, is a venture capital firm based in Chicago, Illinois. The firm focuses on early-stage investments, typically in pre-seed, seed, and Series A rounds, with initial check sizes ranging from $250,000 to $5 million. Lightbank has built a diverse portfolio across various sectors, including consumer, enterprise, healthcare, fintech, and climate tech. Among Lightbank's most notable investments are Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare; Sprout Social, a social media management and marketing platform that went public in 2019; Udemy, an online learning and teaching marketplace with over 155,000 courses; Fiverr, an online marketplace for freelance services, which also went public; and Ovia Health, a women's health and family health company acquired by Labcorp. Lightbank has made a total of 219 investments and has had 91 exits, demonstrating a strong track record of successful investments and strategic exits. The firm's latest investments include companies like Aropha and Ohana Subleasing Co., continuing their commitment to innovative and high-potential startups.

Lightning Ventures is a New York City-based venture capital firm founded in 2021, exclusively focused on Bitcoin and Lightning Network companies. Co-founders include Michael Jarmuz ('Muzz'), who has made over 2,000 personal angel investments with a passion for democratizing retail access to private markets, alongside CTO Uncle 'Rockstar' Dev (formerly of Strike and a major BTCPay Server contributor) and COO Vivek Patel (formerly PrimeTrust, active Bitcoin angel investor). The firm's pilot fund, Node 1, along with its investment syndicate, has deployed over $10 million into 40-plus Bitcoin and adjacent companies. Lightning Ventures invests at pre-seed and seed stages with an average check size of approximately $250,000. The portfolio of 29-plus named companies includes Strike (Bitcoin payments, raised $80 million), Swan Bitcoin, Unchained Capital, Jan3 (most recent investment, Seed in January 2025), Relai, Azteco, CoinCorner, Breez, THNDR Games, Start9, Bitnob, Wavlake, and Ibex. The fund spans software, hardware, mining, and energy companies within the Bitcoin ecosystem, with a geographic reach extending from the United States and Europe to Latin America and Africa. One portfolio exit has been recorded: Slice in October 2025. The firm also launched Thunder Funder, a Regulation CF portal enabling retail investors to invest in open-source and Bitcoin startups for the first time. Lightning Ventures operates with a Bitcoin-only ethos, believing Bitcoin is the global monetary asset of the future. The firm's deal-by-deal syndicate model with low minimum investments is designed to enable diverse investor participation, reflecting the community values embedded in the Bitcoin ecosystem itself. The fund's tight alignment with protocol developers — Rockstar Dev's BTCPay Server contributions being a prime example — gives it proprietary access to technical founders building core Bitcoin infrastructure.

LightShed Ventures is a New York City-based venture capital firm founded in 2020 by Wall Street TMT analysts Richard Greenfield, Walter Piecyk, Brandon Ross, and Jamie Roberts Seltzer. The four General Partners previously co-founded LightShed Partners in 2019, a leading technology, media, and telecommunications research firm serving institutional investors. The venture fund uniquely combines thought-leading TMT research and an active media platform with early-stage venture capital, operating a three-unit flywheel of Research, Media, and Ventures that each reinforce the others. Fund I closed in 2021 with $75 million in capital, with LPs drawn from institutional investors and executives spanning media, telecom, technology, sports, entertainment, music, and finance. LightShed leads rounds and invests primarily at seed and Series A stages in media, technology, telecom, and consumer companies, with a focus on opportunities created by technological disruption in legacy media and communications. The firm has invested in 23 companies through 42 total deals, reflecting active follow-on participation. Average round sizes are $3.91 million at seed and $20.9 million at Series A. Portfolio exits include 5 total, with 4 acquisitions — Supersocial, Podchaser, and Toucan among them — and the most recent exit being Space Perspective in July 2025. The latest investment was Affiniti at Series A in April 2025. The firm averages approximately 2 new investments per year. Rich Greenfield is one of the most closely followed media industry analysts in the country, formerly at BTIG, giving LightShed an unusual combination of public market insight and private market conviction. The firm's research and media presence in Hollywood Reporter, Variety, and Deadline creates a continuous signal about where disruption is emerging in entertainment, streaming, and telecom — which directly informs investment decisions and attracts founders who value knowledgeable, sector-expert investors.

Lightship Capital is a venture capital firm with a distinct mission to empower and invest in underrepresented entrepreneurs. Based in Cincinnati, Ohio, Lightship specifically targets startups led by BIPOC (Black, Indigenous, and People of Color), women, LGBTQ+ individuals, and people with disabilities. Their investments span across the Midwest and South, purposefully avoiding oversaturated markets like Silicon Valley, New York, and Boston. The fund’s industry focus includes sectors such as Consumer Packaged Goods (CPG), E-commerce, Sustainability, Artificial Intelligence (AI), and Health Tech. Notable investments include companies like Healthy Roots Dolls, Vyrill, and ProovTest, which exemplify their commitment to supporting high-growth, impactful businesses. Lightship typically invests at the pre-seed to Series A stages, with an average check size of around $2 million. They are known for actively leading rounds and bringing in Executives-in-Residence with experience from major corporations like Procter & Gamble and Cincinnati Children’s Hospital to support portfolio companies. The firm is led by General Partners Candice Matthews Brackeen and Brian Brackeen, who bring extensive experience in fund management and technology. Their approach to sourcing deals emphasizes building relationships within underrepresented communities and fostering long-term success through hands-on mentorship and strategic guidance. For startups looking to connect with Lightship, aligning with their mission to drive systemic change in the venture capital landscape is crucial.

Lightspeed Venture Partners is a prominent venture capital firm based in Menlo Park, California. Established in 2000, Lightspeed has a rich history of investing in a wide array of sectors including enterprise, consumer, fintech, and healthcare. The firm is known for its deep commitment to supporting companies from seed stage through growth stage. Lightspeed's portfolio includes several high-profile companies. They were early investors in Snapchat, Nutanix, MuleSoft, and AppDynamics, all of which have become significant players in their respective industries. Other notable investments include Affirm, Nest, and Ripple, demonstrating Lightspeed's diverse investment strategy and success across various markets​​. In 2020, Lightspeed raised $4.2 billion across three funds to continue supporting early-stage ventures and growth-stage companies. Their investment philosophy focuses on building strong, enduring companies with a hands-on approach, helping founders navigate the complexities of scaling their businesses​​. With a global presence, Lightspeed operates in several countries including the United States, Israel, India, and China. Their international portfolio reflects their ability to identify and nurture innovative companies worldwide.

Lightstone Ventures, founded in 2012, is a venture capital firm that focuses on early-stage investments in the life sciences sector. The firm is based in Menlo Park, California, with additional offices in Boston and Dublin. Lightstone Ventures has a strong track record of investing in biopharmaceutical and medical device companies. Notable investments by Lightstone Ventures include companies such as Reprieve Cardiovascular, which focuses on innovative treatments for heart failure, and Carrick Therapeutics, a biopharmaceutical company developing treatments for cancer. Another significant investment is in Catamaran Bio, which is advancing cell therapies for cancer. The firm recently closed its third fund at $375 million, which will be used to support early-stage companies developing high-impact therapeutics and technologies. Lightstone Ventures' investment strategy emphasizes translating novel scientific breakthroughs into clinically and commercially meaningful therapies. This approach has resulted in successful exits, such as Ra Pharmaceuticals and Disarm Therapeutics, highlighting their ability to nurture companies from inception to market success.

Lilly Asia Ventures (LAV) is a Shanghai-based biomedical venture capital firm founded in 2008 as the corporate venture arm of Eli Lilly before becoming fully independent in 2011, when it began raising third-party capital with Fund III. Headquartered in Shanghai with offices in Hong Kong and Palo Alto, LAV now manages approximately $4.5 billion in assets across seven funds. Fund VI closed at $1.35 billion in 2021, followed by Fund VII, which reached its $700 million hard cap. Managing Partner Yi Shi has led the firm since its founding, guiding its evolution from a corporate subsidiary into one of Asia's largest independent biomedical venture franchises. LAV invests globally across the full biomedical spectrum — from seed stage to publicly traded companies — in biopharmaceuticals, human therapeutics, medical devices, and diagnostics. The firm leads rounds and has made 326 total investments, achieving 54 portfolio exits. Among the most notable are NASDAQ IPOs for ArriVent, which reached a $575 million market cap in January 2024, and Alector, with a $1.3 billion market cap. Insilico Medicine became LAV's latest unicorn in 2025, exiting in December 2025 just three years after LAV's initial investment. Recent 2025 deals include StairMed Technology, Rona Therapeutics, EnChannel Medical, and a co-led $100 million Series C for Pulnova Medical. LAV's stated vision is to be the trusted partner for exceptional entrepreneurs seeking smart capital to build companies developing breakthrough health products. The firm brings deep scientific networks across Asia and North America, providing portfolio companies with access to clinical development expertise, regulatory knowledge, and global licensing relationships that are particularly valuable when bridging Asian and Western healthcare markets.

Lilly Ventures is the corporate venture capital arm of Eli Lilly and Company, based in Indianapolis, Indiana, and responsible for life science investing across North America and Europe. The fund manages approximately $200 million and operates as a therapeutically agnostic investor, backing companies from early to expansion stage across biotechnology, healthcare IT, and medical technology. It leads rounds and maintains a team of five professionals dedicated to identifying companies that can advance Lilly's drug discovery pipeline while also generating strong financial returns. In January 2025, Eli Lilly announced a landmark $500 million partnership with Andreessen Horowitz to create a new AI-focused biotech venture fund, signaling a major push into AI-driven drug development. The fund has made 84 investments and achieved an exceptional exit record of 36 exits, including 8 NASDAQ IPOs: BioAge Labs reached a $615 million market cap in September 2024, Kymeratx achieved an $863 million market cap, and Coherus Biosciences, Sutro Biopharma, and Protagonist Therapeutics have also gone public. The portfolio has also seen 19 acquisitions. Active portfolio companies include Insilico Medicine, an AI drug discovery firm that received Lilly Ventures' most recent investment in June 2025, alongside basys.ai and Evox Therapeutics. The fund also separately manages a $300 million Social Impact Venture Capital Portfolio targeting investments with measurable patient and societal benefit. Lilly Ventures operates as part of a broader Eli Lilly innovation ecosystem that includes Lilly Gateway Labs and Lilly ExploR&D, allowing portfolio companies to access laboratory infrastructure, scientific talent, and Lilly's global clinical and commercial networks. The fund's strategic alignment with Lilly's therapeutic priorities gives portfolio companies meaningful potential pathways to partnership and acquisition.

LINE Ventures was the corporate venture capital arm of Line Corporation, creator of the LINE messaging app, founded in 2014 and headquartered in Tokyo. In April 2021, following the broader merger of LINE and Yahoo Japan under Z Holdings, LINE Ventures merged with YJ Capital — Yahoo Japan's CVC — to form Z Venture Capital (ZVC). ZVC now serves as the CVC arm of LY Corporation and operates from offices in Tokyo, Seoul, and San Francisco, investing across Japan, South Korea, the United States, and Southeast Asia. The combined entity has managed approximately 185 billion yen (over $1.2 billion) in investments since 2012, with the initial LINE Ventures Global fund launched at $100 million and ZVC's 2021 fund at 30 billion yen. Under the LINE Ventures brand, the firm made 42 investments and achieved 10 exits, including 6 acquisitions. Bear Robotics was acquired by LG in January 2025, and earlier exits included Syte and iPrice. The portfolio spanned software, AI, e-commerce, fintech, gaming, healthtech, and hardware and robotics sectors. ZVC leads rounds and backs startups at seed through Series B with typical checks of $500K to $10 million. ZVC president Shinichiro Hori leads the combined organization. The firm's primary value proposition beyond capital is access to LY Corporation's massive combined user base — the LINE app and Yahoo Japan together reach hundreds of millions of users across Asia. ZVC describes this as 'Value Beyond Capital,' helping portfolio founders rapidly validate products and scale through proprietary distribution channels, making it particularly compelling for consumer-facing startups with regional ambitions.

Lineage Logistics is the world's largest temperature-controlled logistics company, specializing in cold storage and supply chain solutions. With a global footprint spanning over 20 countries and more than 400 facilities, Lineage is a powerhouse in the logistics industry, managing over 2 billion cubic feet of storage space. Founded in 2008 by Bay Grove, Lineage has grown rapidly through strategic acquisitions and innovations in cold chain logistics. Their expertise extends across warehousing, transportation, and automated solutions that enhance efficiency and sustainability in food distribution. In recent years, Lineage has also made significant strides in technology, particularly through Lineage Ventures, its venture capital arm. Launched in 2019, Lineage Ventures focuses on investing in early-stage startups that are developing transformative technologies for the supply chain and logistics sectors. This includes AI-driven software, tech-enabled marketplaces, IoT solutions, and advanced refrigeration technologies. Lineage Ventures collaborates closely with 8VC, a leading venture capital firm, to accelerate innovation and identify startups that can revolutionize the temperature-controlled supply chain. Notable investments include Project44, STORD, and Baton, companies that are redefining logistics and supply chain management through cutting-edge technology. Lineage’s commitment to sustainability is evident in their investments in clean energy projects, including substantial increases in on-site solar installations across their facilities. This approach not only reduces their environmental footprint but also enhances their operational efficiency, reinforcing their leadership in the global logistics sector.

Linear Venture, also known as Linear Capital, is a Shanghai-based early-stage venture capital firm founded in 2014 by Harry Wang — a founding employee of Facebook — and Michael Zhang, a former JD.com and Alibaba Tmall executive. The firm focuses on frontier technology applications, with core investment sectors spanning AI software and applications, AI hardware and embodied intelligence, robotics, new energy and materials, and innovative biomedicine. Linear manages over $2 billion across ten funds, with a combined portfolio valuation of approximately $30 billion and a team that has grown to 23 members with three partners. The firm leads investments from angel through Series A stages, writing checks of $1 million to $10 million per project, and has backed over 170 companies — including 6 unicorns. The most prominent exit is Horizon Robotics, which IPO'd on the Hong Kong Stock Exchange in October 2024 at a $6.69 billion market cap. Other notable exits include Baixing, which listed on the Shanghai Stock Exchange at a $1.34 billion market cap, and the acquisitions of Agile Robots and Dianping. Additional portfolio companies include Tezign, Kujiale, and Rino.ai. Linear made 8 investments in 2024 and continued into 2025 with investments in Final Round AI and Shanghai Weijian Technology. Linear invests across China, Silicon Valley, and Southeast Asia, giving its portfolio companies access to both deep Chinese tech manufacturing ecosystems and global distribution channels. The firm's dual expertise in software applications and hardware manufacturing — particularly in embodied intelligence and robotics — positions it as one of the most active Chinese early-stage technology investors bridging Asian industrial capabilities with global markets.

Link Ventures is a prominent Nordic venture capital firm with a strategic focus on accelerating the energy transition and building scalable technology solutions. Specializing in early-stage investments from pre-seed to Series A, Link Ventures prioritizes sectors such as clean energy, software, mobility, and tech that drive sustainable development. Notable investments by Link Ventures include SolarDuck, an innovative player in marine technology and renewable energy, and Glint Solar, specializing in AI-driven solar energy solutions. They actively invest in startups like Vignita, focusing on B2B corporate training, and Rightcharge, enhancing automotive charging solutions. Geographically, Link Ventures has a strong presence in Nordic and European markets, aiming to support over 100 early-stage companies across Europe. Their investment strategy involves not only financial backing but also active involvement in portfolio companies through strategic support, networking, and board representation. They typically invest between €100,000 to €5M, often leading investment rounds. The team at Link Ventures is led by seasoned professionals including Elisabeth Øvstebø, Founding Partner and Investment Director, and Christian Rangen, Chairman of the Board. They are based in Norway and are recognized for their hands-on approach and commitment to creating high-impact, sustainable businesses. Startups looking to engage with Link Ventures are encouraged to approach with a clear focus on innovation and sustainability, aligning with the firm's mission to foster the next generation of technology that addresses global energy challenges​.

Linse Capital is a growth equity firm that focuses on investing in transformative industrial technology companies across sectors such as transportation, energy, logistics, and real estate. Founded in 2017 and based in Menlo Park, California, the firm seeks to back companies that have the potential to make a profound impact on some of the world's largest industries. Linse Capital is particularly interested in companies driving advancements in electric vehicles, autonomous vehicles, robotics, renewable energy, and space. The firm’s strategy is to invest heavily in a small number of high-conviction bets, typically making capital commitments between $100 million and $400 million per company. Linse Capital's portfolio includes notable companies like ChargePoint (a leader in electric vehicle charging infrastructure), Skydio (an autonomous drone manufacturer), and Redaptive (an energy-as-a-service provider). They focus on deep involvement with their portfolio companies, helping them scale by leveraging Linse’s extensive network and resources. Linse Capital has raised over $1.1 billion in committed capital, backed by a mix of family offices, institutional investors, and strategic partners from industries like transportation and energy​.

LionBird, founded in 2012 and based in Tel Aviv and Chicago, focuses on early-stage investments in digital health companies. The firm targets startups that are leveraging technology to innovate and improve healthcare delivery and outcomes. Their diverse portfolio includes companies such as Ovia Health, a leader in family health solutions; Marqeta, a modern card issuing platform; and Bizzabo, an event management software company. LionBird has achieved notable exits including Ovia Health and Marqeta, which underline their strategic investment approach and successful track record. LionBird recently closed its third fund at $85 million, indicating strong support from institutional investors like the Healthcare of Ontario Pension Plan (HOOPP). This fund is set to invest in 15 to 20 early-stage companies within the digital health sector, reinforcing their commitment to transforming healthcare through technology. The firm is co-founded by Edward Michael JD, Chaim Friedman, and Jonathan Friedman, who bring extensive experience and a strong network to support their portfolio companies. LionBird aims to provide more than just capital, offering strategic guidance and resources to help startups navigate the complexities of the healthcare industry and achieve market fit.

Lionheart Ventures is a venture capital firm based in San Francisco, focused on mitigating civilizational risks through investments in transformative technologies. They primarily target areas like advanced artificial intelligence and frontier mental health technologies. The firm is guided by the belief that addressing these sectors can significantly impact humanity while generating attractive returns for investors. Lionheart Ventures' notable investments include companies like Anthropic, which specializes in developing general AI systems with an emphasis on responsible usage, and Calm, a global health and wellness app aimed at improving mental health through meditation and relaxation tools. Other significant investments are in Beam, a company focused on urban mobility solutions, and Charm Industrial, which works on carbon removal technologies. The firm is led by founders with extensive experience in venture capital and entrepreneurship, ensuring a deep understanding of the challenges and opportunities faced by startups. Their advisory team includes experts in AI safety, psychedelics, and mental health, such as Dr. Joseph Barsuglia and Allison Duettmann, who provide strategic guidance to portfolio companies. For startups looking to engage with Lionheart Ventures, it is essential to align with their mission of developing technologies that can mitigate existential risks and have a meaningful impact on humanity.

Liquid 2 Ventures, founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, is a San Francisco-based venture capital firm specializing in seed-stage investments. The firm focuses on technology startups, aiming to provide early-stage companies with the capital and guidance needed to grow and succeed. Liquid 2 Ventures has made over 400 investments across various sectors, with notable companies including Athelas, Nurx, and Hyperplane AI​​. Liquid 2 Ventures employs a hands-on approach to investing, leveraging the expertise of its founding partners and a strong network of co-investors, including Y Combinator and Soma Capital. The firm's investment strategy centers around identifying innovative technology solutions and supporting them from their earliest stages. Recent investments include companies like Battlesnake, Overjet, and Pry Financials, which showcase their diverse portfolio spanning artificial intelligence, healthcare, and fintech​. For startups seeking to engage with Liquid 2 Ventures, the firm offers substantial support beyond just funding, focusing on building lasting companies through experience, community, and capital. Their commitment to fostering innovation makes them a valuable partner for early-stage technology ventures looking to make a significant impact.

Litani Ventures is a family office established by Peter Rahal, the founder of RXBAR, and is based in Chicago, Illinois, with an additional office in Miami, Florida. Founded in 2018, Litani Ventures focuses on early-stage investments, particularly in consumer products, food tech, and sustainability. The firm leverages Rahal's entrepreneurial background to invest in companies that have the potential to disrupt traditional industries. Litani Ventures operates with a hands-on approach, working closely with founders to provide strategic guidance and operational support. The firm’s investment portfolio includes a variety of innovative companies, such as Cove, a biodegradable materials company, and Zymochem, a biotechnology firm. Litani Ventures has been actively involved in over 66 investments, highlighting its commitment to fostering the growth of promising startups. In addition to direct investments, Litani Ventures is known for its involvement in successful exits, including high-profile companies like Dr. Squatch and Sprout Social. The firm continues to seek new investment opportunities, particularly in areas where it can have a meaningful impact​.

LiveOak Venture Partners, based in Austin, Texas, is a prominent venture capital firm dedicated to investing in early-stage tech and tech-enabled service companies primarily within Texas. Founded in 2012 by Krishna Srinivasan and Venu Shamapant, LiveOak has successfully positioned itself as a leading VC firm focused on nurturing Texas-based startups. The firm has raised three major funds, with the latest being a $210 million Fund III, which surpassed its initial target of $150 million. This makes it the largest Texas-focused early-stage VC fund raised in the past decade. LiveOak's investment strategy is centered on leading or co-leading seed, Series A, and occasionally pre-seed and growth-stage investments, with initial checks ranging from $500K to $10M. They focus on sectors like healthcare technology, information technology, and tech-enabled services. LiveOak's portfolio includes notable companies such as DISCO, OJO Labs, Digital Pharmacist, and Opcity. These companies have either achieved successful exits or have continued to grow under LiveOak’s guidance. The firm prides itself on being deeply involved with its portfolio companies, providing strategic advice, leveraging a vast network, and assisting in crucial hires and growth strategies. LiveOak's commitment to Texas is evident not only in its investment focus but also in its community initiatives like LiveOak Gives, which supports local non-profit organizations. This hands-on, community-oriented approach has helped LiveOak foster a thriving entrepreneurial ecosystem in Texas, contributing significantly to the region's economic growth.

Lockheed Martin, a global leader in aerospace and defense, is heavily invested in advanced technology and strategic ventures through Lockheed Martin Ventures. This arm of the company focuses on early-stage companies innovating in critical areas such as hypersonics, artificial intelligence, cybersecurity, and autonomous systems. A key project for Lockheed Martin is the development of hypersonic weapons and advanced missile defense systems, which are at the forefront of modern warfare technology. These systems push the boundaries of speed and precision, showcasing Lockheed Martin's commitment to maintaining a technological edge. Lockheed Martin Ventures has invested in over 70 companies, supporting advancements that align with the company's strategic goals. These investments reflect Lockheed Martin's dedication to enhancing its capabilities and sustaining leadership in the defense and aerospace sectors. Through these efforts, Lockheed Martin continues to drive innovation and strengthen its position as a technological pioneer in the industry.

Lockstep Ventures is a $50 million venture capital firm dedicated to addressing systemic racial disparities across key areas such as health, wealth, education, and workforce development. Founded with a mission of driving economic justice and generating market-rate returns, Lockstep focuses on investing in founders of color and companies that create impactful solutions for underserved communities in the U.S. Lockstep's investment philosophy, “Disparity to Prosperity,” targets businesses that tackle racial inequality through innovative approaches, particularly in telehealth, financial inclusion, and workforce development. By focusing on sectors where racial disparities are most evident, the firm aims to create scalable solutions that close economic gaps while driving profitability. The firm is co-founded by Marcus Glover, a seasoned investor and advocate for criminal justice reform. Glover’s leadership and deep commitment to social justice have positioned Lockstep Ventures as a force for transformative change, with portfolio companies advancing in sectors like fintech and telehealth. The firm also supports initiatives like Fair Chance hiring, which aims to reduce barriers to employment for formerly incarcerated individuals.

Locus Ventures is a seed-stage venture capital firm founded by alumni from Google, Facebook, and Y Combinator. The firm focuses on investing in early-stage startups with the potential to create significant impact in various industries. Notable companies in their portfolio include Meesho, an online reselling platform; Ironclad, a contract lifecycle management software; and GitLab, a prominent DevOps platform that went public in 2021. Locus Ventures primarily invests in startups within the U.S. and Asia, leveraging their extensive experience and network in Silicon Valley and beyond. Their investment strategy emphasizes close collaboration with founders, providing guidance on product development and market strategy. They are known for their hands-on approach, often leading seed rounds and participating actively in the growth of their portfolio companies. The firm is led by partners Eric Kwan, William Chan, Perry Tam, and Tommy Tsai, who bring diverse backgrounds in technology and entrepreneurship. Locus Ventures has a track record of successful exits, including acquisitions by major companies such as Stripe and Nestlé.

Loeb.nyc is a New York-based venture collective founded by Michael Loeb and Rich Vogel. Rather than functioning as a traditional VC firm, Loeb.nyc offers a unique model that pairs capital investment with deep operational support, creating what they call a "venture collective." This model allows startups to access a wide range of expert resources including marketing, design, operational support, and strategic guidance. The goal is to empower entrepreneurs to focus on scaling their businesses, while Loeb.nyc handles many of the executional challenges that often burden early-stage companies. With a focus on direct-to-consumer, fintech, health, and tech solutions, Loeb.nyc’s portfolio is diverse and designed to foster collaboration between companies. Some notable portfolio companies include Fetch Rewards, a popular mobile app that helps shoppers save money, and InsightRX, which optimizes healthcare outcomes through precision medicine. By fostering a collaborative startup ecosystem, Loeb.nyc enables its companies to share resources and best practices, enhancing their chances of success. The leadership duo of Michael Loeb and Rich Vogel brings over three decades of entrepreneurial and investment experience, having previously built billion-dollar businesses like Synapse Group. Their hands-on approach and focus on community-building make Loeb.nyc a key player in the early-stage startup ecosystem.

Lofty Ventures is a Chicago-based angel investment community and micro venture fund founded in 2014 by Christopher Deutsch and Spencer Gordon-Sand. The firm describes itself as a convergence of Chicago's best founders and resources, investing at pre-seed and seed stages in startups primarily based in the city. With a four-person team writing checks of $10,000 to $100,000, with a sweet spot of $25,000, Lofty operates at a scale designed to catalyze first rounds for nascent Chicago companies while maintaining a strong focus on supporting underrepresented founders. The firm has participated in approximately 11 tracked portfolio deals across software, SaaS, consumer goods, and healthtech sectors. The standout exit is Cubii, a maker of portable seated fitness devices, which was acquired by Gridiron Capital for a reported $100 million — the fund's most significant return to date. SHYFT Power Solutions exited in November 2024. Other portfolio companies include Gather Voices, WeCasa, UpKey, Bridge Money, Paladin, 4Degrees, Resonado, Arvist, and PairUp, the fund's most recent investment from July 2024. Beyond writing checks, Lofty runs active community programming for its portfolio, including founder dinners and the Women of Lofty initiative, reflecting the firm's emphasis on community building as a competitive advantage. While operating at angel and micro-VC scale, Lofty has carved a distinctive niche as one of Chicago's most community-oriented early-stage investment groups, helping build the city's next generation of technology companies through both capital and sustained founder relationships.

LOI Venture is a $20 million seed-stage venture capital fund founded in 2021 by Ryan Holmes — co-founder of Hootsuite — and Manny Padda, based in Vancouver, Canada. The fund is closely tied to the League of Innovators (LOI), a nonprofit founded by Holmes in 2017 to accelerate the growth of young entrepreneurs across Canada. LOI Venture backs founders aged 17 to 30 who participate in the LOI program, writing checks of approximately $100,000 per investment across a sector-agnostic mandate spanning consumer, enterprise, deep tech, fintech, impact, hardware, and software. The fund operates with a team of 29 people including 18 partners and has invested in 33 companies across Canada, the United States, and India. Notable portfolio companies include Blossom and Spontivly. The fund primarily targets seed-stage rounds with an average round size of $1.03 million and has also participated in Series A rounds averaging $5.3 million. LOI Venture runs an AI cohort program and LOI Labs batches — Batch 11 featured 59 ventures. Community events include fireside chats with entrepreneurs such as Mark Cuban and Brian Scudamore, and the annual Young Entrepreneur of the Year awards. LOI Venture's defining differentiator is its integration with the League of Innovators pipeline, which provides a continuous funnel of vetted young founders with community accountability and peer support built in. The fund's approach positions capital as one component of a broader growth platform, giving founders access to mentorship networks, programming resources, and a cohort community that extends well beyond the initial investment.

London Real Ventures is a London-based venture capital firm founded in 2023 by Brian Rose as the investment arm of London Real, a media company broadcasting since 2011 with over 9.6 million subscribers, more than 1 billion views, and 1,000+ guest interviews. The firm describes itself as the world's first media-powered investment firm, targeting Web3, AI, and metaverse companies from pre-seed through Series A. The fund has made approximately 70 investments across blockchain technology, AI, fintech, gaming, and media sectors, with portfolio companies spread across the United States, France, Brazil, and other markets. London Real Ventures bundles each investment with a comprehensive media package: a two-hour, six-camera HD interview with Brian Rose, a Hollywood-style trailer, 15 to 20 short video clips, professional photography, and distribution across YouTube, Instagram, Facebook, and X to the global subscriber base. This media exposure constitutes a meaningful portion of the firm's value proposition. Portfolio companies include Shrapnel, a AAA blockchain game that reportedly achieved a 10x return on its token generation event using London Real's media distribution, OrdinalsBot, Defi Gold, Merlin Starter, and SwissBorg. Bluwhale closed a Series A in January 2025, and Zarqa was the most recent investment in December 2025. Beyond media amplification, London Real Ventures provides portfolio companies with introductions to multibillion-dollar fund managers, Layer 1 blockchain protocol CEOs, and major content creators. Brian Rose also founded The Crypto and DeFi Academy, positioning the firm at the intersection of media distribution, community building, and early-stage Web3 capital.